KMT2A and leukemia: The initial attempt was to use RNA interference (RNAi) to inhibit MYB. In a mouse model of MLL-AF9 leukemia, MYB specific shRNA effectively silenced MYB and showed that its inhibition could eradicate invasive leukemia in vivo without affecting normal myelopoiesis [134].